Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,587 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Los Angeles CA, Santa Barbara CA, Santa Cruz CA,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase 2, Recruiting

International Rare Histiocytic Disorders Registry (IRHDR)

for
Rare Histiocytic Disorders (RHDs),
Location: Los Angeles CA, Madera CA, Birmingham AL, Pittsburgh PA,
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0+

Code: NCT02285582

Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Los Angeles CA, Duarte CA, Stanford CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase 3, Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

for
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed
Location: Los Angeles CA, Palo Alto CA, Phoenix AZ,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 2 - 40

Code: NCT05634369

Phase 1, Phase 2, Recruiting

The Myelin Disorders Biorepository Project

for
Leukodystrophy, White Matter Disease, Leukoencephalopathies,
Location: Los Angeles CA, Orange CA, San Diego CA, Palo Alto CA,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT03047369

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Los Angeles CA, Santa Barbara CA, Rancho Mirage CA,
Sponsor: Edwards Lifesciences

Sex: All

Age: 65+

Code: NCT04889872

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Los Angeles CA, Aurora CO, Calgary, Dallas TX, Edmonton,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 0 - 25

Code: NCT04094610

Phase 1, Phase 2, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase 2, Recruiting

mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

for
Urothelial Bladder Cancer, Muscle-Invasive Bladder Cancer
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06335667

Recruiting

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: Duarte CA, Palo Alto CA, Dallas TX, Pittsburgh PA,
Sponsor: RefleXion Medical

Sex: All

Age: 0+

Code: NCT05406167

Recruiting

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Duarte CA, Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05136846

Phase 1, Recruiting

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
Location: Torrance CA, Redlands CA, Santa Barbara CA,
Sponsor: University of British Columbia

Sex: All

Age: 0+

Code: NCT04634240

Recruiting

Precise Infliximab Exposure and Pharmacodynamic Control

for
Crohn Disease
Location: Los Angeles CA, San Diego CA, Palo Alto CA,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 6 - 22

Code: NCT05660746

Phase 2, Phase 3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Duarte CA, Irvine CA, La Jolla CA, Eugene OR, Calgary,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Long Beach CA, Orange CA, Fresno CA, Stanford CA,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701669

Phase 2, Recruiting

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

for
Insomnia Disorder
Location: Irvine CA, Las Vegas NV, Phoenix AZ, Great Falls MT,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 2 - 17

Code: NCT06953869

Phase 3, Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

for
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung,
Location: Fullerton CA, Grand Junction CO, Golden CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06758401

Phase 3, Recruiting

Onyx™ Liquid Embolic IDE Clinical Study

for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Los Angeles CA, Irvine CA, Palo Alto CA, Phoenix AZ,
Sponsor: Medtronic Endovascular

Sex: All

Age: 22+

Code: NCT06742801

Recruiting

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Los Angeles CA
Sponsor: Yuan Yuan

Sex: All

Age: 18+

Code: NCT05318469

Phase 1, Phase 2, Recruiting

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

for
Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced,
Location: Los Angeles CA, Long Beach CA, Orange CA,
Sponsor: University of Michigan

Sex: All

Age: 0 - 17

Code: NCT05376267

Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles